Boobalan Pachaiyappan

Brandon Folkes

David Hoang

Scott Henry

Robert Hazlett

Matthew Kaplan

Matt Kaplan

- The New York Supreme Court has upheld its original summary judgment ruling in favor of RedHill Biopharma Ltd. against Kukbo Co. Ltd., unequivocally dismissing Kukbo's defense and confirming RedHill's fulfillment of agreement obligations.  **[1553846_0001178913-25-003401_zk2533819.htm:1]** 
- RedHill Biopharma has been granted approximately **$10 million in total awards**, which includes an **$8.25 million original award** and a subsequent **$1.82 million award** for legal costs and expenses, along with 9% statutory interest accrual.  **[1553846_0001178913-25-003401_zk2533819.htm:1]** 
- Kukbo Co. Ltd. retains the right to further appeal the Court's ruling.  **[1553846_0001178913-25-003401_zk2533819.htm:1]** 
- In addition to the New York Supreme Court case, RedHill Biopharma recently secured an attachment grant against Kukbo from Korea's Incheon District Court, allowing for a court-ordered seizure of Kukbo's assets.  **[1553846_0001178913-25-003401_zk2533819.htm:1]**

RedHill Biopharma (RDHL)